- Home
- BCAB vs SINT Comparison
BCAB vs SINT Comparison
Compare BCAB & SINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BCAB | SINT |
|---|---|---|
| Founded | 2007 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.5M | 11.7M |
| IPO Year | 2020 | 2007 |
Fundamental Metrics
Financial Performance| Metric | BCAB | SINT |
|---|---|---|
| Price | $0.15 | $2.59 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | $1.00 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 1.3M | 30.0K |
| Earning Date | 05-05-2026 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 44.19 | ★ 59.45 |
| EPS | ★ N/A | N/A |
| Revenue | $300,000.00 | ★ $1,018,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $80.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.13 | $1.72 |
| 52 Week High | $1.43 | $6.78 |
Technical Indicators
Market Signals| Indicator | BCAB | SINT |
|---|---|---|
| Relative Strength Index (RSI) | 38.23 | 37.56 |
| Support Level | $0.13 | $2.60 |
| Resistance Level | $0.21 | $2.96 |
| Average True Range (ATR) | 0.02 | 0.15 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 1.82 | 40.31 |
Price Performance
Historical ComparisonAbout BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.
About SINT SiNtx Technologies Inc.
SINTX Technologies Inc is a ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming a renowed ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have good bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.